AGL

agilon health, inc. (AGL) ESG Analysis Analysis (2026)

Invetso Score: 4.8/10 — Balanced · Last Updated: 2026-08-01

Overall Score

Environmental

No material environmental disclosures or ESG news were provided this month.

Capital intensity remains low relative to revenue, but there is no fresh evidence of improved environmental performance.

Social

No material social disclosures or ESG news were provided this month.

Operating performance remains weak, which limits evidence of positive stakeholder outcomes.

Governance

No material governance disclosures or ESG news were provided this month.

Balance sheet leverage remains modest, but profitability and cash generation are still negative.

Overall Esg

No material ESG-specific news was provided this month.

Weak profitability and negative free cash flow continue to constrain the overall ESG profile.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on agilon health, inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →